Adenoscan and Sustol
Determining the interaction of Adenoscan and Sustol and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Before getting treatment with adenosine, let your doctor know if you are currently using granisetron. Combining these medications can increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Adenosine has induced torsade de pointes arrhythmia in patients with preexisting long QT syndrome. Theoretically, coadministration of adenosine with agents that can prolong the QT interval may increase that risk as well. The mechanism has not been established, but may involve the depressant effect of adenosine on the sinoatrial and atrioventricular nodes. Rare cases of severe bradycardia have been reported during treatment with adenosine, which could favor the occurrence of torsade de pointes, especially in patients with prolonged QT intervals. Interestingly, no case of torsade de pointes has been reported when adenosine is given by continuous infusion.
MANAGEMENT: Adenosine should be used with caution in patients receiving drugs that may prolong the QT interval. Adenosine should be discontinued immediately if severe bradycardia occurs.
- Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6
- Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75
- Drescher MJ, Mendelssohn R "Transient torsades de pointes after adenosine." Isr J Trauma Intensive Care Emerg Med 2 (2002): 15-7
- Cerner Multum, Inc. "Australian Product Information." O 0
- Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422
- Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301
- Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."
- Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10
Generic Name: adenosine
Brand name: Adenocard, Adenoscan, Adeno-jec, My-O-Den, Myoden
Synonyms: n.a.
Generic Name: granisetron
Brand name: Sustol, Kytril, Sancuso
Synonyms: Sustol (injection), Sustol Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adenoscan-Sustol injection
- Adenoscan-SuTan
- Adenoscan-SuTan-DM
- Adenoscan-Sutent
- Adenoscan-Suvorexant
- Adenoscan-Swabflush flush
- Sustol-Adenosine
- Sustol-Adenosine Intravenous
- Sustol-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Sustol-Adenovirus Vaccine
- Sustol-Adenovirus vaccine, live
- Sustol-Adhansia XR